HIGHLIGHTS
- Who: Sherif Hanafy Mahmoud and collaborators from the University of Alberta, Canada have published the research work: Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy, in the Journal: (JOURNAL)
- Future: Identifying the most effective target for improving diastolic dysfunction remains uncertain highlighting the need for future studies to explore these mechanisms in T2D subjects.
SUMMARY
Diabetes has evolved exponentially, affects 463 million people worldwide, and prevalence is expected to increase to 700 million by 2045. Despite numerous advancements in the management of hyperglycemia, cardiovascular diseases including myocardial infarction . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.